Markets.com Logo

59JA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    654.1658$
  • Previous Close
    650.4966$
  • 52 Week Change
    155.36$
  • Day Range
    3.67$
  • 52 Week High/Low
    509.6424$ - 665$
  • Dividend Per Share
    6.1644
  • Market cap
    4 578 M$
  • EPS
    --
  • Beta
    --
  • Volume
    --

About

59JA.F is the ticker symbol for shares of JD Logistics Inc. traded on the Frankfurt Stock Exchange (FSE). JD Logistics is a leading supply chain solutions and logistics services provider in China, offering services such as warehousing, transportation, last-mile delivery, and technology solutions. Investors can use this ticker symbol to track the price and performance of JD Logistics shares on the Frankfurt Stock Exchange. However, it's important to note that the price in Frankfurt might be influenced by currency exchange rates and market conditions specific to the FSE, and may not directly mirror the price on other exchanges where JD Logistics might be listed.

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist

Emma Rose|--

Iran War Threatens US Labor Market's 'Wonderful Balance': A Deep Dive

Emma Rose|--

Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment

Sophia Claire|--

US Labor Market Outlook: Balancing Recovery Against Escalating Geopolitical Risks

Sophia Claire|--

Global Debt Crisis Deepens Amidst Iran Conflict and Fiscal Fragility

Ava Grace|--

Apple's Strategic Pivot: MacBook Neo, Supply Chain Tactics, and Foldable Phone Hurdles

Emma Rose|--

Factors

Company Performance: Jaguar Health's financial health, including revenue growth, profitability, and debt levels, significantly impacts its stock price. Positive earnings reports typically lead to price increases, while losses often result in declines.

Clinical Trial Results: As a biopharmaceutical company, Jaguar Health's stock price is highly sensitive to the outcomes of its clinical trials for novel drugs. Successful trial data can trigger substantial price appreciation, whereas unfavorable results may cause a sharp sell-off.

Regulatory Approvals: Securing regulatory approvals from agencies like the FDA for its drug candidates is crucial for Jaguar Health's commercial prospects. Approvals typically lead to stock price gains, reflecting investor confidence in future revenue streams.

Market Sentiment: Overall market conditions and investor sentiment toward the biotechnology sector influence Jaguar Health's stock price. Bull markets often lift biotech stocks, while bear markets can depress them, regardless of company-specific news.

Competition: The competitive landscape within the biopharmaceutical industry affects Jaguar Health's market share and potential revenues. The emergence of new competitors or more effective treatments can negatively impact its stock price.

Partnerships and Acquisitions: Strategic alliances, licensing agreements, or potential acquisitions involving Jaguar Health can significantly alter its stock valuation. Positive partnerships or acquisition rumors typically boost the stock price.

Analyst Ratings: Investment analysts' ratings and price targets for Jaguar Health can influence investor perception and trading activity. Upgrades from analysts often lead to increased buying pressure, while downgrades can trigger selling.

News and Media Coverage: News articles, research reports, and media coverage related to Jaguar Health can impact investor sentiment and trading volume. Positive news can drive the stock price higher, while negative news can have the opposite effect.

Macroeconomic Factors: Broader economic factors, such as interest rates, inflation, and economic growth, can influence investor risk appetite and capital allocation. Higher interest rates may reduce the attractiveness of growth stocks like Jaguar Health.

Share Dilution: Issuance of new shares can dilute existing shareholders' ownership and potentially decrease the stock price. Announcements of secondary offerings or equity financing often lead to temporary price declines.

People Also Watch

Latest news

Close Coordination Between Israel and US on Iran Nuclear Talks Highlighted

Noah Lee|--

US-Iran Talks Show Progress Towards Ceasefire Framework Agreement

Liam James|--

Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure

Liam James|--

Latest Education Articles

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Beginners Guide to Fundamental Analysis: What Are the 5 Key Principles of Fundamental Analysis?

Frances Wang|--
Bull vs. Bear Markets: What's the Difference?

Bull vs. Bear Markets: What's the Difference?

Julian Parker|--
Recommended Topics